Activation of is an important mechanism in apoptosis. localization in mitochondria and apoptosis. Together the data indicate that the presence of p53 in mitochondria plays an important role in stress-induced apoptosis and suggest that NPM may protect cells from apoptosis by reducing the mitochondrial level of p53. The tumor suppressor functions of are mediated by inhibiting the growth of defective cells through activation of cell cycle arrest and apoptosis (1-3). The apoptotic function of plays a critical role in its MK-2206 2HCl tumor suppressor activity (3). p53 level is increased upon exposure to various stimuli including DNA damage oncogenic stimuli hypoxia (4) and oxidative stress (5 6 Recently the linkage between mitochondrial oxidative MK-2206 2HCl stress and transactivates several mitochondrial proapoptotic proteins including Bax a member of the family (8); Noxa a BH3-only member of the family (9); and release and caspase activation (11-13). Therefore it has been suggested that may mediate apoptosis by mechanisms that are both dependent on and independent of its transcriptional activity thus amplifying its apoptotic function. is considered to be the guardian of the genome. To enhance the efficiency of p53-dependent transcription of target genes as well as to protect the genome from damage p53 stabilization is required. It has been reported that NPM (nucleophosmin) a nucleolar phosphoprotein implicated in ribosome biogenesis (14) stabilizes and regulates the transcriptional activity of (15). acts as a molecular chaperone and shuttle between the nucleus and cytoplasm (16). The enhancement of p53 stability and transcriptional ability of may occur through several mechanisms including inhibition of Mdm2 ubiquitin-ligase activity competition with p53-Mdm2 bindings and NPM chaperonage of p53 (15 17 The stability of p53 proteins is primarily regulated by Mdm2 a ubiquitin E3 ligase and Arf a nucleolar protein that binds with p53 and inhibits the ubiquitin ligase activity of Mdm2 for p53 (18). Colombo (19) have reported that lack of expression in suppresses is overexpressed in many types of human cancer including colon (20) ovarian (21) prostate (22) and gastric (23) cancer. It has been proposed that has both antiapoptotic and apoptotic capabilities depending on its level and subcellular localization (15 16 24 25 Malignant and actively dividing cells expressing large amounts of NPM are resistant to apoptosis (20 22 induced by UV damage or hypoxia (14 26 Similar to other proto-oncogenes overexpression is primarily associated with cell proliferation (27) suggesting that may act as a Mouse monoclonal to KLF15 proto-oncogene by promoting cell survival. It has been demonstrated that NPM may also act as a co-activator for the transcription of survival genes including is mediated via is not known. Our study shows that does not play a major role in is associated with its ability to suppress p53 localization to mitochondria. This is the first study to demonstrate the role of NPM in blocking mitochondrial p53 and preventing siRNA were purchased from Santa Cruz Biotechnology. Doxorubicin MK-2206 2HCl and TPA were purchased from Bedford Laboratories (Bedford OH) and Sigma respectively. Transient Transfection Cells were grown for 24 h with no antibiotics to obtain 70-80% confluence. The cells were then transfected with plasmids following a Lipofectamine? transfection protocol as directed by the manufacturer. Cells were transfected with 4 μg of cDNA construct in plasmid vector or (?gene silencing is as follows: antisense 5 sense 5 The 2-bp mismatch siRNA (used to verify the specificity of silencing) sequence is as follows: antisense 5 2 min at 4 °C to obtain cell pellets. Cell pellets were then resuspended in buffer A containing 10 mm HEPES (pH 7.9) 1.5 mm MgCl2 10 mm KCl 0.5 mm dithiothreitol and 0.2 mm phenylmethylsulfonyl fluoride with the inclusion of protease inhibitors (pepstatin aprotinin and leupeptin) at a concentration of 1 1 μg/ml. Additionally the phosphatase inhibitors NaF (5 mm) and Na3VO4 (1 mm) were included. The cell suspension was incubated on ice for 15 min. 12.5 μl of 10% Nonidet P-40 was added and the mixture was vigorously vortexed for 15 s. The cytoplasmic and nuclear fractions were separated by centrifugation at 17 0 × at MK-2206 2HCl 4 °C for 30 s. Subsequently the nuclear pellets were resuspended in buffer B containing.